8 Recruiting Pancreatic Cancer Clinical Trials in Maryland
Explore active pancreatic cancer research studies enrolling across Maryland. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceRecruiting Pancreatic Cancer Studies in Maryland
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas Cancer
📍 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas
📍 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 📋 Clinical Research Protocol
Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma
📍 Johns Hopkins Hospital — Baltimore, Maryland
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer
📍 Johns Hopkins SKCCC — Baltimore, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
📍 Johns Hopkins Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer
📍 Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland
View Study & Checklist ➔